BioMimetic Therapeutics Announces Positive Results;
GEM OS1 Stimulates Bone Healing Comparable to Autograft
Dec. 13, 2006
|
|
|
BioMimetic Therapeutics to Announce Interim U.S. Clinical Trial Results for GEM OS1;
Press Release and Conference Call Scheduled for Dec. 13
Dec. 12, 2006
|
|
|
BioMimetic Therapeutics Reports Third Quarter 2006 Results
Nov. 6, 2006
|
|
|
BioMimetic Therapeutics' Clinical Investigator Highlights Results
of Orthopedic Clinical Trial in Canada
Nov. 6, 2006
|
|
|
BioMimetic Therapeutics' Clinical Investigator to Present Orthopedic Clinical Results
from Canadian Trial on November 4; Company to Report Third Quarter Financial Results
Nov. 2, 2006
|
|
|
BioMimetic Therapeutics Receives FDA Approval that Expands Manufacturing Capacity
for GEM 21S® ; Approval of rhPDGF-BB Manufacturing Facility
Oct. 13, 2006
|
|
|
BioMimetic Therapeutics Adds Key Talent to Board of Directors
Sep. 27, 2006
|
|
|
BioMimetic Therapeutics' Clinical Investigator Provides Results Demonstrating
Long-Term Efficacy for GEM 21S Treatment; Data Shows Continued Benefits
in Bone Growth for up to 2 Years after Treatement
Sep. 18, 2006
|
|
|
BioMimetic Therapeutics, Inc. to Highlight Corporate Activities
at the AG Edwards Emerging Growth Conference
Sep. 15, 2006
|
|
|
BioMimetic Therapeutics' Clinical Investigators to Receive Award
from American Academy of Periodontology for Outstanding Publication;
Clinical Investigators to Present Data at Annual AAP Meeting
Sep. 14, 2006
|
|
|
BioMimetic Therapeutics Reports Second Quarter 2006 Results;
Orthopedic Clinical Trial Progress Highlights 2006 Second Quarter
Aug. 9, 2006
|
|
|
BioMimetic Therapeutics Posts Webcast re: Second Quarter 2006 Financial Results
Aug. 7, 2006
|
|
|
BioMimetic Therapeutics Successfully Completes Enrollment in Three Orthopedic
Pilot Clinical Trials for GEM OS1™ Bone Graft; Canadian Study Expanded to 60 Patients
July 11, 2006
|
|
|
BioMimetic Therapeutics to Highlight Corporate Activities
at Pacific Growth Equities Life Science Growth Conference
June 8, 2006
|
|
|
BioMimetic Therapeutics Receives Approval to Market
GEM 21S® Growth-factor Enhanced Matrix in Canada
June 7, 2006
|
|
|
Dr. Samuel E. Lynch Presides Over the NASDAQ Closing Bell to Celebrate
the Initial Public Offering of BioMimetic Therapeutics, Inc. [BMTI]
March 20, 2006
|
|
|
BioMimetic Therapeutics, Inc. Announces Pricing of Initial Public Offering
May 12, 2006
|
|
|
BioMimetic Therapeutics Initiates Clinical Trials with Novel
Bio-Active Drug-device Combination Bone Graft in Two Orthopedic Indications
March 20, 2006
|
|
|
BioMimetic Therapeutics, Inc. Files Registration Statement for Initial Public Offering
Feb. 10, 2006
|
|
|
